(Q44280764)

English

The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption--a nation-wide perspective in Sweden

scientific article published in June 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption--a nation-wide perspective in Sweden (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Håkan Askmark

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Karolina Antonov

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sten-Magnus Aquilonius

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Parkinsonism and Related Disorders

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

271-276

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is levodopa toxic?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Levodopa in the treatment of Parkinson's disease: a consensus meeting

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine agonists and neuroprotection in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine agonists: their role in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Utilization of antiparkinson drugs in Norway, Sweden, Denmark and Finland 1975-1979

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological assessment of levodopa use by populations

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Levodopa use in Denmark: high levels in Greenland and the Faroe Islands. Europarkinson Preparatory Activity Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1353-8020(02)00117-7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44280764&oldid=2109108428"